Ambev S.A.
NYSE:ABEVBeverages - Alcoholic
-$0.02 today
- Market cap
- $42.89B
- Beta
- 0.27
- P/E (TTM)
- 16.2
- EPS (TTM)
- $1.00
- Dividend yield
- 9.76%
Volume 11.24M
Average 27.73M
ABEV Total Current Liabilities
All obligations due within one year.
Ambev S.A.NYSE: ABEV
Total Current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total current liabilities rises 7.5% from a year ago
Total current liabilities stood at R$39.62B at the end of Q2 FY2026, up 7.5% from a year earlier and down 4.9% from the prior quarter. Over 3 fiscal years it compounded at +4.0% a year.
Context
- Total current liabilities amounted to 28.7% of total assets at the end of Q2 FY2026, up 2.7 pp from a year earlier.
- Total current liabilities increased in 2 of the last 3 fiscal years.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +7.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
BRL · from the balance sheet
- Latest · FY2025
- 45.6B BRL
- Year-over-year change
- -7.7%
- 4-year CAGR
- +4.1%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 45.6B | -7.7% |
| FY2024 | 2024-12-31 | 49.39B | +20.4% |
| FY2023 | 2023-12-31 | 41.01B | +1.1% |
| FY2022 | 2022-12-31 | 40.54B | +4.3% |
| FY2021 | 2021-12-31 | 38.87B | — |
Total Current Liabilities vs competitors
How ABEV compares with its peers on the latest reported figures
- Peers report in different currencies, so total current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +7.5% is the 3rd highest of 6, against a peer median of +7.2%.
- Total current liabilities amounts to 28.7% of total assets for ABEV, versus a peer median of 19.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | CLP 741.93B CLP | -6.9% | +0.0% | 19.8% | |
| Jun 2026 | R$39.62B BRL | +7.5% | +4.0% | 28.7% | |
| Jun 2026 | $33.48B USD | +1.4% | +0.1% | 15.3% | |
| Jun 2026 | $13.7B USD | +7.2% | -59.6% | 29.8% | |
| Jun 2026 | $5.21B USD | +60.8% | +16.3% | 21.4% | |
| Aug 2026 | $2.96B USD | +11.4% | -3.2% | 13.4% | |
| Peer median (excluding ABEV) | — | +7.2% | +0.0% | 19.8% | |
Competitors are the stored peer set for ABEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 16.63B | 14.93B | 16.06B | 28.6B | 18.64B |
| Short-term Investments | 1.91B | 454.5M | 277.2M | 1.24B | 1.68B |
| Net Receivables | 4.79B | 8.2B | 9.18B | 9.85B | 10.23B |
| Inventory | 11B | 12.92B | 9.62B | 11.69B | 10.52B |
| Other Current Assets | 4.29B | 1.31B | 1.43B | 2.78B | 2.09B |
| Total Current Assets | 38.63B | 37.82B | 36.56B | 54.16B | 43.88B |
| Property, Plant & Equipment (Net) | 29.22B | 30.06B | 26.63B | 30.17B | 27.64B |
| Goodwill | 42.41B | 40.59B | 38B | 44.34B | 41.54B |
| Intangible Assets | 8.69B | 9.22B | 10.04B | 12.53B | 11.04B |
| Long-term Investments | 498.1M | 551M | 531.3M | 579.9M | 1.26B |
| Tax Assets | 4.73B | 6.44B | 7.97B | 59K | 11.43B |
| Other Non-current Assets | 14.42B | 13.28B | 12.9B | 20.73B | 11.32B |
| Total Non-current Assets | 99.98B | 100.14B | 96.08B | 108.35B | 104.24B |
| Total Assets | 138.6B | 137.96B | 132.64B | 162.51B | 148.11B |
| Account Payables | 25.08B | 24.33B | 23.2B | 25.22B | 22.6B |
| Short-term Debt | 224.6M | 273.3M | 151.2M | 163.6M | 1.17B |
| Tax Payables | 6.08B | 6.93B | 7.58B | 7.59B | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.97B | 4.42B | 5.28B | 4.03B | 14.25B |
| Total Current Liabilities | 38.87B | 40.54B | 41.01B | 49.39B | 45.6B |
| Long-term Debt | 267.2M | 454.3M | 391M | 324M | 2.22B |
| Deferred Tax Liabilities | 3.21B | 3.73B | 3.32B | 5.01B | 6.94B |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 10.25B | 7.58B | 5.97B | 6.35B | 2.62B |
| Total Non-current Liabilities | 15.72B | 14.09B | 11.5B | 13.54B | 13.74B |
| Total Liabilities | 54.58B | 54.63B | 52.5B | 62.93B | 59.34B |
| Common Stock | 58.04B | 58.13B | 58.18B | 58.23B | 58.28B |
| Retained Earnings | 0 | 0 | 0 | 0 | 18.04B |
| Accumulated OCI | 86.38B | 92.25B | 98.67B | 108.97B | 14.55B |
| Other Stockholders Equity | (61.78B) | (68.42B) | (77.88B) | (68.56B) | 0 |
| Minority Interest | 1.37B | 1.37B | 1.17B | 938.4M | 860.74M |
| Total Equity | 84.02B | 83.33B | 80.14B | 99.58B | 88.77B |
| Total Debt | 3.13B | 3.85B | 3.5B | 3.45B | 5.35B |
| Net Debt | (13.5B) | (11.08B) | (12.56B) | (25.14B) | (13.29B) |
Ambev S.A.
NYSE:ABEV
Intrinsic Alpha fair value
Locked
Current Price
$2.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.